Bloomberg News

Evogene Advances Most in Two Months on Monsanto Agreement

November 30, 2011

(Updates with closing share price in second paragraph.)

Nov. 29 (Bloomberg) -- Evogene Ltd. rose the most in more than two months after the developer of plant traits for the agriculture and biofuel industries extended and expanded a collaboration agreement with Monsanto Co.

The shares increased 5.5 percent, the biggest gain since Sept. 26, to 14.96 shekels at the 4:30 p.m. close in Tel Aviv.

--Editors: Shanthy Nambiar, Peter Branton

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net


Cash Is for Losers
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus